The development of drugs targeting the IL-7 gene for autoimmune diseases and cancer seems very promising, particularly the use of recombinant IL-7 proteins, IL-7 gene vaccines, IL-7 receptor antagonists, and IL-7 signalling pathway blockers. This evidence concerns the gene IL7 and cancer.